Skip to main content
Erschienen in: Calcified Tissue International 2/2017

08.02.2017 | Editorial

Diabetes and Bone

verfasst von: Serge Ferrari

Erschienen in: Calcified Tissue International | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Diabetes and osteoporosis are two of the most common chronic disorders which prevalence increases worldwide, eventually affecting hundreds of millions of people. The environmental, primarily nutritional, conditions that predispose to diabetes and osteoporosis, respectively, appear quite different, but there may be some common genetic factors predisposing to both disorders. Although the morphotype of subjects developing type 2 diabetes as a consequence of overweight and the metabolic syndrome seems protective against fractures, and is certainly far from the image of the frail elderly with bone fragility, type 2 diabetes is increasingly recognized as an independent risk factor for fractures—at least in the bone community, although not yet broadly recognized as a complication of glucose impairment in the diabetes community. The risk of fragility fractures is even higher among the leaner patients with type 1 diabetes, whose long-standing disease is associated with an up to fivefold higher hip fracture risk, which incidence starts to rise 10–15 years before the exponential rise observed in the non-diabetic population. The relative contribution of decreased bone strength, in particular bone “quality,” and increased incidence of injurious falls, to the higher fracture risk among diabetics remains unknown. …
Literatur
1.
Zurück zum Zitat Hough FS, Pierroz D, Cooper C, Ferrari S, The IOF CSA Bone and Diabetes Working Group (2016) Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol 174(4):R127–R138CrossRefPubMed Hough FS, Pierroz D, Cooper C, Ferrari S, The IOF CSA Bone and Diabetes Working Group (2016) Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol 174(4):R127–R138CrossRefPubMed
2.
Zurück zum Zitat Nicola N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, IOF Bone and Diabetes Working Group (2016) Mechanisms of diabetes-induced bone fragility. Nat Rev Endocrinol. doi:10.1038/nrendo.2016.153 Nicola N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, IOF Bone and Diabetes Working Group (2016) Mechanisms of diabetes-induced bone fragility. Nat Rev Endocrinol. doi:10.​1038/​nrendo.​2016.​153
Metadaten
Titel
Diabetes and Bone
verfasst von
Serge Ferrari
Publikationsdatum
08.02.2017
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 2/2017
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-017-0234-y

Weitere Artikel der Ausgabe 2/2017

Calcified Tissue International 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.